Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Diabetologia|April 1, 1991
Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistanceP Skøtt, A Vaag, N E Bruun, et al.
Kidney International|April 1, 1992
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patientsH H Parving, M A Gall, P Skøtt, et al.
Diabetes, Obesity & Metabolism|April 8, 2014
Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trialM J Davies, J L Gross, Y Ono, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 18, 2006
Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetesK Kølendorf, G P Ross, I Pavlic-Renar, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1992
Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathyM A Gall, P Rossing, E Hommel, et al.
Diabetes|July 1, 1995
On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathyF S Nielsen, P Rossing, L E Bang, et al.
Diabetologia|May 1, 1993
Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathyF S Nielsen, A I Voldsgaard, M A Gall, et al.
Diabetologia|September 1, 1991
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patientsM A Gall, P Rossing, P Skøtt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2005
Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetesM Hollingdal, J Sturis, M-A Gall, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 26, 2009
Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trialR G Moses, P Bartley, H Lunt, et al.
Pageof 5